AG˹ٷ

STOCK TITAN

[8-K] Alto Ingredients, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Magnera (MAGN) Q3 FY25 10-Q highlights post-merger scale but strained profitability. Net sales rose 51% YoY to $839 million (YTD $2.37 billion, +45%), mainly from the Nov-24 Glatfelter acquisition; organic volume slipped ~5%. Cost of goods sold jumped 53%, squeezing margin and cutting operating income 24% to $13 million. A new $1.99 billion debt stack pushed quarterly interest expense to $37 million, swinging the quarter to a $(18 million) loss (-$0.51/sh) versus $19 million profit last year; YTD loss is $(119 million).

Cash climbed to $276 million, but YTD operating cash flow was only $7 million; management still targets FY25 free cash flow of $75-95 million on ~$75 million capex. Leverage now approaches ~5× EBITDA, though covenants are solely negative. Integration/restructuring charges ran $14 million this quarter ($69 million YTD); expected annual synergies are $55 million and a $20 million capacity rationalisation is planned. Segment view: Americas revenue +22% to $473 million, margin 2.5%; Rest-of-World revenue +118% to $366 million, near breakeven. A $50 million currency-translation gain lifted comprehensive income to $32 million. Shares outstanding: 35.6 million (6 Aug 25).

Magnera (MAGN) Q3 FY25 10-Q: evidenti i benefici della scala post-fusione ma la redditività resta sotto pressione. Le vendite nette sono aumentate del 51% su base annua, raggiungendo 839 milioni di dollari (YTD 2,37 miliardi, +45%), principalmente grazie all'acquisizione di Glatfelter a novembre 2024; il volume organico è diminuito di circa il 5%. Il costo del venduto è salito del 53%, comprimendo il margine e riducendo l'utile operativo del 24% a 13 milioni di dollari. Un nuovo indebitamento di 1,99 miliardi di dollari ha fatto salire le spese per interessi trimestrali a 37 milioni, trasformando il trimestre in una perdita di 18 milioni di dollari (-0,51 dollari per azione) rispetto a un utile di 19 milioni dell'anno precedente; la perdita YTD è di 119 milioni di dollari.

La liquidità è salita a 276 milioni, ma il flusso di cassa operativo YTD è stato solo di 7 milioni; la direzione prevede ancora un flusso di cassa libero per l'anno fiscale 25 tra 75 e 95 milioni su un capex di circa 75 milioni. La leva finanziaria si avvicina ora a circa 5× EBITDA, anche se i covenant sono solo di tipo negativo. Le spese di integrazione e ristrutturazione sono state di 14 milioni questo trimestre (69 milioni YTD); le sinergie annuali previste sono di 55 milioni e si pianifica una razionalizzazione della capacità da 20 milioni. Vista per segmenti: ricavi Americas +22% a 473 milioni, margine 2,5%; ricavi Rest-of-World +118% a 366 milioni, vicino al pareggio. Un guadagno da conversione valutaria di 50 milioni ha portato il reddito complessivo a 32 milioni. Azioni in circolazione: 35,6 milioni (6 agosto 2025).

Magnera (MAGN) Q3 FY25 10-Q: destaca la escala tras la fusión, pero la rentabilidad está presionada. Las ventas netas aumentaron un 51% interanual hasta 839 millones de dólares (YTD 2,37 mil millones, +45%), principalmente por la adquisición de Glatfelter en noviembre de 2024; el volumen orgánico cayó alrededor del 5%. El costo de bienes vendidos subió un 53%, reduciendo el margen y disminuyendo el ingreso operativo un 24% a 13 millones de dólares. Una nueva deuda de 1,99 mil millones incrementó el gasto por intereses trimestral a 37 millones, resultando en una pérdida de 18 millones de dólares (-0,51 dólares por acción) frente a una ganancia de 19 millones el año anterior; la pérdida acumulada es de 119 millones.

El efectivo subió a 276 millones, pero el flujo de caja operativo YTD fue solo de 7 millones; la dirección aún apunta a un flujo de caja libre para FY25 de 75-95 millones con un capex de aproximadamente 75 millones. El apalancamiento se acerca a ~5× EBITDA, aunque los convenios son solo negativos. Los cargos por integración/reestructuración fueron de 14 millones este trimestre (69 millones YTD); se esperan sinergias anuales de 55 millones y se planea una racionalización de capacidad de 20 millones. Vista por segmento: ingresos en Americas +22% a 473 millones, margen 2,5%; ingresos en Rest-of-World +118% a 366 millones, casi en equilibrio. Una ganancia por traducción de moneda de 50 millones elevó el ingreso integral a 32 millones. Acciones en circulación: 35,6 millones (6 agosto 2025).

Magnera (MAGN) FY25 3분기 10-Q: 합병 � 규모 확대� 뚜렷하지� 수익성은 압박받음. 순매출은 전년 대� 51% 증가� 8� 3,900� 달러(연초 누적 23� 7천만 달러, +45%)�, 주로 2024� 11� Glatfelter 인수� 기인�; 유기� 판매량은 � 5% 감소. 매출원가� 53% 증가� 마진� 압박하고 영업이익은 24% 감소� 1,300� 달러� 그침. 신규 19� 9천만 달러 부채로 분기 이자 비용� 3,700� 달러� 상승하며, 이번 분기 1,800� 달러 손실(주당 -0.51달러)� 기록, 전년 동기 1,900� 달러 이익에서 적자� 전환; 연초 누적 손실은 1� 1,900� 달러�.

현금은 2� 7,600� 달러� 증가했으�, 연초 누적 영업 현금 흐름은 700� 달러� 불과; 경영진은 여전� 연간 자유 현금 흐름 7,500만~9,500� 달러� 목표� 하며, � 7,500� 달러� 자본 지출을 계획 �. 레버리지� 현재 � 5� EBITDA� 근접, 다만 계약 조건은 부정적 약정� 포함. 통합 � 구조조정 비용은 이번 분기 1,400� 달러(연초 누적 6,900� 달러); 연간 예상 시너지 효과� 5,500� 달러이며, 2,000� 달러 규모� 생산 능력 합리� 계획 �. 부문별 실적: 아메리카 매출 22% 증가� 4� 7,300� 달러, 마진 2.5%; 기타 지� 매출 118% 증가� 3� 6,600� 달러, 거의 손익분기�. 5,000� 달러 환율 변� 이익으로 포괄손익은 3,200� 달러 상승. 발행 주식 �: 3,560� �(2025� 8� 6� 기준).

Magnera (MAGN) T3 FY25 10-Q : mise en évidence de la taille post-fusion mais rentabilité sous pression. Les ventes nettes ont augmenté de 51 % en glissement annuel pour atteindre 839 millions de dollars (YTD 2,37 milliards, +45 %), principalement grâce à l’acquisition de Glatfelter en novembre 2024 ; le volume organique a légèrement reculé d’environ 5 %. Le coût des marchandises vendues a bondi de 53 %, comprimant la marge et réduisant le résultat opérationnel de 24 % à 13 millions de dollars. Une nouvelle dette de 1,99 milliard de dollars a fait grimper les charges d’intérêts trimestrielles à 37 millions, entraînant une perte trimestrielle de 18 millions de dollars (-0,51 $/action) contre un bénéfice de 19 millions l’an dernier ; la perte YTD s’élève à 119 millions.

La trésorerie a augmenté à 276 millions, mais le flux de trésorerie opérationnel YTD n’était que de 7 millions ; la direction vise toujours un flux de trésorerie disponible FY25 de 75-95 millions avec environ 75 millions de dépenses d’investissement. L’endettement approche désormais environ 5× l’EBITDA, bien que les clauses restrictives soient uniquement négatives. Les charges d’intégration/restructuration se sont élevées à 14 millions ce trimestre (69 millions YTD) ; les synergies annuelles attendues sont de 55 millions et une rationalisation de capacité de 20 millions est prévue. Vue par segment : chiffre d’affaires Amériques +22 % à 473 millions, marge 2,5 % ; chiffre d’affaires Reste du Monde +118 % à 366 millions, proche de l’équilibre. Un gain de change de 50 millions a porté le résultat global à 32 millions. Actions en circulation : 35,6 millions (6 août 2025).

Magnera (MAGN) Q3 FY25 10-Q: Nach der Fusion deutliche Skaleneffekte, aber belastete Profitabilität. Der Nettoumsatz stieg im Jahresvergleich um 51 % auf 839 Millionen US-Dollar (YTD 2,37 Milliarden, +45 %), hauptsächlich durch die Übernahme von Glatfelter im November 2024; das organische Volumen sank um ca. 5 %. Die Herstellungskosten stiegen um 53 %, was die Marge drückte und das Betriebsergebnis um 24 % auf 13 Millionen US-Dollar reduzierte. Ein neuer Schuldenberg von 1,99 Milliarden US-Dollar erhöhte die Quartalszinsaufwendungen auf 37 Millionen, wodurch das Quartal mit einem Verlust von 18 Millionen US-Dollar (-0,51 US-Dollar je Aktie) abschloss, nach einem Gewinn von 19 Millionen im Vorjahr; der Verlust YTD beträgt 119 Millionen.

Der Kassenbestand stieg auf 276 Millionen, aber der operative Cashflow YTD betrug nur 7 Millionen; das Management peilt weiterhin einen Free Cashflow für FY25 von 75-95 Millionen bei etwa 75 Millionen Capex an. Die Verschuldung nähert sich nun etwa dem 5-fachen EBITDA, wobei die Covenants nur negativ sind. Integrations- und Restrukturierungskosten beliefen sich in diesem Quartal auf 14 Millionen (69 Millionen YTD); erwartete jährliche Synergien betragen 55 Millionen, und eine Kapazitätsanpassung von 20 Millionen ist geplant. Segmentübersicht: Americas-Umsatz +22 % auf 473 Millionen, Marge 2,5 %; Rest der Welt-Umsatz +118 % auf 366 Millionen, nahezu ausgeglichen. Ein Währungsumrechnungsgewinn von 50 Millionen steigerte das Gesamtergebnis auf 32 Millionen. Ausstehende Aktien: 35,6 Millionen (6. August 2025).

Positive
  • Revenue up 51% YoY to $839 million, demonstrating immediate scale benefits from Glatfelter acquisition.
  • Cash balance $276 million plus undrawn $350 million revolver provide liquidity headroom.
  • Management projects $55 million annual cost synergies and FY25 free cash flow of $75-95 million.
  • Currency translation gain $50 million lifted comprehensive income into positive territory.
Negative
  • Quarterly net loss $(18 million) vs $19 million profit prior year; YTD loss $(119 million).
  • Long-term debt ballooned to $1.99 billion, raising interest expense to $37 million (vs $1 million).
  • Operating cash flow only $7 million YTD, casting doubt on FCF guidance.
  • Organic volumes declined ~5% and pricing eroded, indicating underlying demand softness.
  • $69 million YTD integration/restructuring costs continue to pressure margins.

Insights

TL;DR: Strong top-line boost from Glatfelter deal, but debt-fuelled interest and integration costs drive losses; cash adequate near-term.

The 51% revenue surge confirms the strategic logic of adding Glatfelter’s fiber portfolio, yet underlying demand is soft (-5% organic volume, lower pricing). Gross margin fell ~520 bps as purchase-accounting step-ups and inflation offset scale benefits. Interest coverage is now below 1×, reflecting $1.6 billion fresh borrowings and two secured note issues; absence of maintenance covenants limits default risk but constrains future financing flexibility. Cash of $276 million plus an unused $350 million revolver covers near-term needs, though only $7 million YTD operating cash flow questions the $75-95 million FCF guide. Management’s $55 million synergy target is critical to restoring EBIT; execution risk remains high.

TL;DR: Elevated leverage, rising rates, and integration friction tilt risk profile negative despite synergy upside.

Net leverage nearing 5× and 7.25% secured notes amplify sensitivity to rate moves; a 25 bp SOFR uptick adds ~$2 million annual interest. Integration spending and a $12 million inventory step-up already cut operating cash, and $20 million planned rationalisation may strain relations with European labour forces. Foreign-currency exposure remains material; a 10% FX move could shave $2 million from quarterly net income despite hedges. Environmental liabilities ($18 million Fox River) and a contingent $56 million tax claim create additional tail risks. Overall credit quality hinges on timely synergy capture and margin recovery.

Magnera (MAGN) Q3 FY25 10-Q: evidenti i benefici della scala post-fusione ma la redditività resta sotto pressione. Le vendite nette sono aumentate del 51% su base annua, raggiungendo 839 milioni di dollari (YTD 2,37 miliardi, +45%), principalmente grazie all'acquisizione di Glatfelter a novembre 2024; il volume organico è diminuito di circa il 5%. Il costo del venduto è salito del 53%, comprimendo il margine e riducendo l'utile operativo del 24% a 13 milioni di dollari. Un nuovo indebitamento di 1,99 miliardi di dollari ha fatto salire le spese per interessi trimestrali a 37 milioni, trasformando il trimestre in una perdita di 18 milioni di dollari (-0,51 dollari per azione) rispetto a un utile di 19 milioni dell'anno precedente; la perdita YTD è di 119 milioni di dollari.

La liquidità è salita a 276 milioni, ma il flusso di cassa operativo YTD è stato solo di 7 milioni; la direzione prevede ancora un flusso di cassa libero per l'anno fiscale 25 tra 75 e 95 milioni su un capex di circa 75 milioni. La leva finanziaria si avvicina ora a circa 5× EBITDA, anche se i covenant sono solo di tipo negativo. Le spese di integrazione e ristrutturazione sono state di 14 milioni questo trimestre (69 milioni YTD); le sinergie annuali previste sono di 55 milioni e si pianifica una razionalizzazione della capacità da 20 milioni. Vista per segmenti: ricavi Americas +22% a 473 milioni, margine 2,5%; ricavi Rest-of-World +118% a 366 milioni, vicino al pareggio. Un guadagno da conversione valutaria di 50 milioni ha portato il reddito complessivo a 32 milioni. Azioni in circolazione: 35,6 milioni (6 agosto 2025).

Magnera (MAGN) Q3 FY25 10-Q: destaca la escala tras la fusión, pero la rentabilidad está presionada. Las ventas netas aumentaron un 51% interanual hasta 839 millones de dólares (YTD 2,37 mil millones, +45%), principalmente por la adquisición de Glatfelter en noviembre de 2024; el volumen orgánico cayó alrededor del 5%. El costo de bienes vendidos subió un 53%, reduciendo el margen y disminuyendo el ingreso operativo un 24% a 13 millones de dólares. Una nueva deuda de 1,99 mil millones incrementó el gasto por intereses trimestral a 37 millones, resultando en una pérdida de 18 millones de dólares (-0,51 dólares por acción) frente a una ganancia de 19 millones el año anterior; la pérdida acumulada es de 119 millones.

El efectivo subió a 276 millones, pero el flujo de caja operativo YTD fue solo de 7 millones; la dirección aún apunta a un flujo de caja libre para FY25 de 75-95 millones con un capex de aproximadamente 75 millones. El apalancamiento se acerca a ~5× EBITDA, aunque los convenios son solo negativos. Los cargos por integración/reestructuración fueron de 14 millones este trimestre (69 millones YTD); se esperan sinergias anuales de 55 millones y se planea una racionalización de capacidad de 20 millones. Vista por segmento: ingresos en Americas +22% a 473 millones, margen 2,5%; ingresos en Rest-of-World +118% a 366 millones, casi en equilibrio. Una ganancia por traducción de moneda de 50 millones elevó el ingreso integral a 32 millones. Acciones en circulación: 35,6 millones (6 agosto 2025).

Magnera (MAGN) FY25 3분기 10-Q: 합병 � 규모 확대� 뚜렷하지� 수익성은 압박받음. 순매출은 전년 대� 51% 증가� 8� 3,900� 달러(연초 누적 23� 7천만 달러, +45%)�, 주로 2024� 11� Glatfelter 인수� 기인�; 유기� 판매량은 � 5% 감소. 매출원가� 53% 증가� 마진� 압박하고 영업이익은 24% 감소� 1,300� 달러� 그침. 신규 19� 9천만 달러 부채로 분기 이자 비용� 3,700� 달러� 상승하며, 이번 분기 1,800� 달러 손실(주당 -0.51달러)� 기록, 전년 동기 1,900� 달러 이익에서 적자� 전환; 연초 누적 손실은 1� 1,900� 달러�.

현금은 2� 7,600� 달러� 증가했으�, 연초 누적 영업 현금 흐름은 700� 달러� 불과; 경영진은 여전� 연간 자유 현금 흐름 7,500만~9,500� 달러� 목표� 하며, � 7,500� 달러� 자본 지출을 계획 �. 레버리지� 현재 � 5� EBITDA� 근접, 다만 계약 조건은 부정적 약정� 포함. 통합 � 구조조정 비용은 이번 분기 1,400� 달러(연초 누적 6,900� 달러); 연간 예상 시너지 효과� 5,500� 달러이며, 2,000� 달러 규모� 생산 능력 합리� 계획 �. 부문별 실적: 아메리카 매출 22% 증가� 4� 7,300� 달러, 마진 2.5%; 기타 지� 매출 118% 증가� 3� 6,600� 달러, 거의 손익분기�. 5,000� 달러 환율 변� 이익으로 포괄손익은 3,200� 달러 상승. 발행 주식 �: 3,560� �(2025� 8� 6� 기준).

Magnera (MAGN) T3 FY25 10-Q : mise en évidence de la taille post-fusion mais rentabilité sous pression. Les ventes nettes ont augmenté de 51 % en glissement annuel pour atteindre 839 millions de dollars (YTD 2,37 milliards, +45 %), principalement grâce à l’acquisition de Glatfelter en novembre 2024 ; le volume organique a légèrement reculé d’environ 5 %. Le coût des marchandises vendues a bondi de 53 %, comprimant la marge et réduisant le résultat opérationnel de 24 % à 13 millions de dollars. Une nouvelle dette de 1,99 milliard de dollars a fait grimper les charges d’intérêts trimestrielles à 37 millions, entraînant une perte trimestrielle de 18 millions de dollars (-0,51 $/action) contre un bénéfice de 19 millions l’an dernier ; la perte YTD s’élève à 119 millions.

La trésorerie a augmenté à 276 millions, mais le flux de trésorerie opérationnel YTD n’était que de 7 millions ; la direction vise toujours un flux de trésorerie disponible FY25 de 75-95 millions avec environ 75 millions de dépenses d’investissement. L’endettement approche désormais environ 5× l’EBITDA, bien que les clauses restrictives soient uniquement négatives. Les charges d’intégration/restructuration se sont élevées à 14 millions ce trimestre (69 millions YTD) ; les synergies annuelles attendues sont de 55 millions et une rationalisation de capacité de 20 millions est prévue. Vue par segment : chiffre d’affaires Amériques +22 % à 473 millions, marge 2,5 % ; chiffre d’affaires Reste du Monde +118 % à 366 millions, proche de l’équilibre. Un gain de change de 50 millions a porté le résultat global à 32 millions. Actions en circulation : 35,6 millions (6 août 2025).

Magnera (MAGN) Q3 FY25 10-Q: Nach der Fusion deutliche Skaleneffekte, aber belastete Profitabilität. Der Nettoumsatz stieg im Jahresvergleich um 51 % auf 839 Millionen US-Dollar (YTD 2,37 Milliarden, +45 %), hauptsächlich durch die Übernahme von Glatfelter im November 2024; das organische Volumen sank um ca. 5 %. Die Herstellungskosten stiegen um 53 %, was die Marge drückte und das Betriebsergebnis um 24 % auf 13 Millionen US-Dollar reduzierte. Ein neuer Schuldenberg von 1,99 Milliarden US-Dollar erhöhte die Quartalszinsaufwendungen auf 37 Millionen, wodurch das Quartal mit einem Verlust von 18 Millionen US-Dollar (-0,51 US-Dollar je Aktie) abschloss, nach einem Gewinn von 19 Millionen im Vorjahr; der Verlust YTD beträgt 119 Millionen.

Der Kassenbestand stieg auf 276 Millionen, aber der operative Cashflow YTD betrug nur 7 Millionen; das Management peilt weiterhin einen Free Cashflow für FY25 von 75-95 Millionen bei etwa 75 Millionen Capex an. Die Verschuldung nähert sich nun etwa dem 5-fachen EBITDA, wobei die Covenants nur negativ sind. Integrations- und Restrukturierungskosten beliefen sich in diesem Quartal auf 14 Millionen (69 Millionen YTD); erwartete jährliche Synergien betragen 55 Millionen, und eine Kapazitätsanpassung von 20 Millionen ist geplant. Segmentübersicht: Americas-Umsatz +22 % auf 473 Millionen, Marge 2,5 %; Rest der Welt-Umsatz +118 % auf 366 Millionen, nahezu ausgeglichen. Ein Währungsumrechnungsgewinn von 50 Millionen steigerte das Gesamtergebnis auf 32 Millionen. Ausstehende Aktien: 35,6 Millionen (6. August 2025).

false 0000778164 0000778164 2025-08-06 2025-08-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 6, 2025

 

ALTO INGREDIENTS, INC.

 

(Exact Name of Registrant as Specified in Charter)

 

Delaware   000-21467   41-2170618
(State or Other Jurisdiction   (Commission File Number)   (IRS Employer
of Incorporation)       Identification No.)

 

1300 South Second Street
Pekin, Illinois
  61554
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (833) 710-2586

 

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  Trading Symbol(s)  Name of each exchange on which registered
Common Stock, $0.001 par value  ALTO  The Nasdaq Stock Market LLC
(Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On August 6, 2025, Alto Ingredients, Inc. issued a press release announcing certain results of operations for the three and six months ended June 30, 2025. A copy of the press release is furnished (not filed) as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information furnished in this Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 2.02 of this Current Report on Form 8-K is not incorporated by reference into any filings of Alto Ingredients, Inc. made under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing unless specifically stated so therein.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Number  Description
99.1  Press Release dated August 6, 2025
104  Cover Page Interactive Data File (formatted as Inline XBRL)

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 6, 2025 ALTO INGREDIENTS, INC.
   
  By: /S/ AUSTE M. GRAHAM
    Auste M. Graham,
    Chief Legal Officer and Secretary

 

2

 

FAQ

How did Magnera (MAGN) perform financially in Q3 FY25?

Net sales rose 51% to $839 million, but higher costs and $37 million interest expense produced a $(18 million) net loss (-$0.51 per share).

Why did Magnera’s debt increase to nearly $2 billion?

The company issued an $781 million term loan and $1.3 billion of secured notes to finance the Nov-24 Glatfelter acquisition and a cash distribution to former parent Berry Global.

What synergy savings are expected from the Glatfelter transaction?

Management forecasts $55 million in annual cost synergies net of standalone costs once integration is complete.

What is Magnera’s liquidity position after the quarter?

Cash stood at $276 million with no borrowings on the $350 million revolver; leverage is ~5× EBITDA but there are no financial maintenance covenants.

What free cash flow does Magnera project for FY25?

The company guides to $75-95 million post-transaction free cash flow, assuming ~$75 million in capital expenditures.

How did each segment perform?

Americas revenue +22% to $473 m with 2.5% margin; Rest-of-World revenue +118% to $366 m, near breakeven operating income.
Alto Ingredients Inc

NASDAQ:ALTO

ALTO Rankings

ALTO Latest News

ALTO Latest SEC Filings

ALTO Stock Data

80.30M
71.63M
7.23%
38.43%
0.59%
Specialty Chemicals
Industrial Organic Chemicals
United States
SACRAMENTO